デフォルト表紙
市場調査レポート
商品コード
1378969

医療用食品市場レポート:製品、投与経路、用途、流通チャネル、地域別、2023-2028年

Medical Foods Market Report by Product, Route of Administration, Application, Distribution Channel, and Region 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
医療用食品市場レポート:製品、投与経路、用途、流通チャネル、地域別、2023-2028年
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の医療用食品市場規模は2022年に220億米ドルに達しました。今後、IMARC Groupは、この市場は2028年までに307億米ドルに達し、2022~2028年の成長率(CAGR)は5.7%になると予測しています。消費者の健康意識の高まり、若年および高齢の消費者の間で健康状態を管理するための栄養ソリューションへの志向の高まり、ゲノミクスとその他の先端技術の統合などが、市場成長を促進する主な要因のひとつです。

医療用食品は、特定の病状の食事管理のために医学的管理の下で使用されることを意図して特別に処方された食品です。通常の食品とは異なり、医療用食品は特定の栄養要件を満たすように作られており、特定の食事調整が必要な疾患または病状の管理に使用されることが多いです。例えば、栄養吸収不良や代謝障害、特定の種類の食物アレルギーに悩む人に処方されることがあります。注意しなければならないのは、医療用食品は栄養補助食品とは異なるということです。栄養補助食品は食事を補うためのものであるのに対し、医療用食品は医学的に診断された明確な栄養欠乏や不均衡を管理するためのものです。医療用食品は、厳格な安全基準と表示基準を含む規制を遵守しなければならないです。こうした製品は一般にヘルスケア・プロバイダーを通じてのみ入手可能であり、包括的な治療計画の一環として使用されるべきです。

消費者の健康意識の高まりが、世界市場を大きく牽引しています。消費者は健康管理により積極的になりつつあり、治療計画の一環として特殊な食品を使用するという考えを受け入れやすくなっています。さらに、若い消費者も高齢の消費者も、健康状態を管理するための栄養ソリューションへの傾倒を示しています。そのため、消費者教育や健康アドバイスを提供するデジタル・プラットフォームの台頭が、この動向にいっそう拍車をかけています。医療用食品市場の成長に寄与している重大な要因の1つは、世界の高齢化人口の増加です。高齢者はしばしば、栄養不良、栄養吸収能力の低下、アルツハイマー病やパーキンソン病などの慢性疾患など、複数の健康課題に直面します。特に先進国では高齢者の割合が増え続けており、高齢者特有のニーズに合わせてカスタマイズされた医療用食品の需要が高まると予想されます。さらに、ゲノム学やその他の先端技術のヘルスケアへの統合により、個別化された栄養摂取が可能になりつつあるため、医療用食品にはかなりの市場機会がもたらされています。さらに、研究開発における官民のパートナーシップが、市場の見通しを明るいものにしています。

医療用食品の市場動向と促進要因:

慢性疾患の有病率の増加

医療用食品業界の市場促進要因のひとつは、糖尿病、心血管障害、代謝症候群などの慢性疾患の有病率の上昇です。慢性疾患はしばしば、症状を管理し生活の質を向上させるために特定の栄養学的介入が必要となります。医療提供者や患者が、こうした症状の管理に食事が果たす役割について認識を深めるにつれて、特殊な医療用食品の需要が加速しています。例えば、糖尿病を管理するために調合された医療用食品は、血糖値のコントロールを助け、それによって薬物療法の必要性を減らし、合併症を軽減することができます。こうした的を絞った栄養ソリューションは、従来の医療療法を補完し、時には副作用の少ない医薬品の代替品を提供することもあります。このような慢性疾患の有病率の増加と、医学的に管理された食事管理の利点に関する意識の高まりとが相まって、医療用食品の拡大に有利な市場環境が形成されつつあります。

栄養科学の進歩

栄養科学と研究の急速な進展も市場促進要因の1つであり、これによってますます効果的な医療用食品が処方されるようになっています。さらに、細胞レベルおよび代謝レベルでの栄養素の役割に対する理解が深まったことで、特定の状態に合わせた製品の開発が可能になっています。この科学的革新により、先天性代謝異常や特定の胃腸障害など、従来の治療法では十分でない疾患の的確な治療が可能になっています。食品技術の進歩はまた、より嗜好性が高く、摂取しやすく、保存性の高い医療用食品の製造を可能にし、それによって利用者のコンプライアンスを向上させています。研究が進展するにつれて、さまざまな病状の人々特有の栄養要件を満たすよう設計された、より幅広い種類の医療用食品に対する需要が高まっており、それによって市場の成長に拍車がかかっています。

規制面のサポートと標準化

医療用食品業界は、製品の安全性と有効性を確保する強固な規制の枠組みからも恩恵を受けています。これに関連して、規制当局は医療用食品の分類、ラベリング、および販売に関するガイドラインを明確に定めています。このことは、ヘルスケア提供者にも消費者にも信頼感を与え、こうした特殊製品の処方と使用を促しています。これとは別に、厳格な基準を遵守することにより、医療用食品が認知された科学的原則に基づく特定の栄養ニーズを満たすことが保証されます。こうした規制面の支援は、医療用食品業界を信頼できる不可欠なヘルスケアの一部として確立し、その成長を促進することに貢献しています。

本レポートで扱う主な質問

  • 2022年の世界の医療用食品市場規模は?
  • 2023~2028年の世界の医療用食品市場の予想成長率は?
  • COVID-19が世界の医療用食品市場に与えた影響は?
  • 医療用食品の世界市場を牽引する主要因は何か
  • 医療用食品の世界市場の製品別区分は?
  • 投与経路に基づく医療用食品の世界市場内訳は?
  • 医療用食品の世界市場の用途別区分は?
  • 医療用食品の世界市場の流通経路別区分は?
  • 医療用食品の世界市場における主要地域は?
  • 10.医療用食品の世界市場における主要プレーヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の医療用食品市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品別

  • 錠剤
    • 市場動向
    • 市場予測
  • 粉末
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳:投与経路別

  • 経口
    • 市場動向
    • 市場予測
  • 経腸
    • 市場動向
    • 市場予測

第8章 市場内訳:用途別

  • ADHD
    • 市場動向
    • 市場予測
  • うつ病
    • 市場動向
    • 市場予測
  • 糖尿病
    • 市場動向
    • 市場予測
  • がん
    • 市場動向
    • 市場予測
  • アルツハイマー病
    • 市場動向
    • 市場予測
  • 代謝性疾患
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:流通チャネル別

  • スーパーマーケット
    • 市場動向
    • 市場予測
  • 病院・薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Alfasigma S.p.A.
    • Danone S.A.
    • Fresenius Kabi AG
    • Mead Johnson & Company LLC(Reckitt Benckiser)
    • Medtrition Inc.
    • Meiji Holdings Co. Ltd.
    • Metagenics Inc.(Alticor)
    • Nestle S.A.
    • Primus Pharmaceuticals Inc.
    • Targeted Medical Pharma Inc.
    • Victus Inc.
図表

List of Figures

  • Figure 1: Global: Medical Foods Market: Major Drivers and Challenges
  • Figure 2: Global: Medical Foods Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Medical Foods Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Medical Foods Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Medical Foods Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Medical Foods Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Medical Foods Market: Breakup by Distribution Channel (in %), 2022
  • Figure 8: Global: Medical Foods Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Medical Foods (Pills) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Medical Foods (Pills) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Medical Foods (Powder) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Medical Foods (Powder) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Medical Foods (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Medical Foods (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Medical Foods (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Medical Foods (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Medical Foods (Enteral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Medical Foods (Enteral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Medical Foods (ADHD) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Medical Foods (ADHD) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Medical Foods (Depression) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Medical Foods (Depression) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Medical Foods (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Medical Foods (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Medical Foods (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Medical Foods (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Medical Foods (Alzheimer's Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Medical Foods (Alzheimer's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Medical Foods (Metabolic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Medical Foods (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Medical Foods (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Medical Foods (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Medical Foods (Supermarkets) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Medical Foods (Supermarkets) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Medical Foods (Hospital and Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Medical Foods (Hospital and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Medical Foods (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Medical Foods (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Medical Foods (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Medical Foods (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: North America: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: North America: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United States: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United States: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Canada: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Canada: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Asia-Pacific: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Asia-Pacific: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: China: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: China: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: India: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: India: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: South Korea: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: South Korea: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Australia: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Australia: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Indonesia: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Indonesia: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Europe: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Europe: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Germany: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Germany: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: France: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: France: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: United Kingdom: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: United Kingdom: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Italy: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Italy: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Spain: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Spain: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Russia: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Russia: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Latin America: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Latin America: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Brazil: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Brazil: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Mexico: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Mexico: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Middle East and Africa: Medical Foods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Middle East and Africa: Medical Foods Market: Breakup by Country (in %), 2022
  • Figure 89: Middle East and Africa: Medical Foods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Global: Medical Foods Industry: SWOT Analysis
  • Figure 91: Global: Medical Foods Industry: Value Chain Analysis
  • Figure 92: Global: Medical Foods Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Medical Foods Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Medical Foods Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Medical Foods Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Medical Foods Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Medical Foods Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 6: Global: Medical Foods Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Medical Foods Market: Competitive Structure
  • Table 8: Global: Medical Foods Market: Key Players
目次
Product Code: SR112023A3637

Abstract

The global medical foods market size reached US$ 22.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 30.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.7% during 2022-2028. The escalating health consciousness among consumers, the growing inclination toward nutritional solutions for managing health conditions among younger and older consumers, and the integration of genomics and other advanced technologies are among the key factors driving the market growth.

Medical foods are specially formulated food products intended to be used under medical supervision for the dietary management of specific medical conditions. Unlike regular foods, medical foods are created to meet specific nutritional requirements and are often used to manage diseases or conditions that require particular dietary adjustments. For instance, they may be prescribed for individuals suffering from nutrient malabsorption, metabolic disorders, or specific types of food allergies. It's crucial to note that medical foods are not the same as dietary supplements. While dietary supplements are intended to supplement the diet, medical foods are meant to manage a distinct nutritional deficiency or imbalance that is medically diagnosed. Medical foods must comply with regulations, which include rigorous safety and labeling standards. These products are generally only available through healthcare providers and should be used as part of a comprehensive medical treatment plan.

The increasing health consciousness among consumers majorly drives the global market. Consumers are becoming more proactive about managing their health and are more receptive to the idea of using specialized foods as part of their treatment plan. Additionally, both younger and older consumers are showing an inclination toward nutritional solutions for managing health conditions. Thus, the rise in consumer education and digital platforms offering health advice has further fueled this trend. One crucial factor contributing to the growth of the medical foods market is the global increase in the aging population. Older adults often face multiple health challenges, including malnutrition, reduced ability to absorb nutrients and chronic conditions such as Alzheimer's and Parkinson's diseases. As the percentage of the elderly continues to grow, especially in developed countries, the demand for medical foods customized to meet their specific needs is expected to rise. In addition, the integration of genomics and other advanced technologies into healthcare is making personalized nutrition a possibility, thereby offering a considerable market opportunity for medical foods. Moreover, public and private partnerships in research and development are creating a positive market outlook.

Medical Foods Market Trends/Drivers:

Increasing Prevalence of Chronic Diseases

One of the significant market drivers for the medical foods industry is the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and metabolic syndromes. Chronic conditions often necessitate specific nutritional interventions to manage symptoms and improve quality of life. As healthcare providers and patients become more aware of the role that diet plays in managing these conditions, the demand for specialized medical foods is accelerating. For instance, medical foods formulated to manage diabetes can help control blood sugar levels, thereby reducing the need for medication and mitigating complications. Such targeted nutritional solutions can complement traditional medical therapies, sometimes offering an alternative to pharmaceuticals with fewer side effects. This increasing prevalence of chronic diseases, coupled with growing awareness about the benefits of medically supervised dietary management, is creating a favorable market environment for the expansion of medical foods.

Advancements in Nutritional Science

Another market driver is the rapid progress in nutritional science and research, which has led to the formulation of increasingly effective medical foods. Additionally, the deepening understanding of the role of nutrients at the cellular and metabolic levels has made it possible to develop products tailored to specific conditions. This scientific innovation allows for the precise treatment of diseases like inborn errors of metabolism or certain gastrointestinal disorders where conventional therapies might not suffice. Advancements in food technology have also enabled the production of medical foods that are more palatable, easy to consume, and shelf-stable, thereby enhancing user compliance. As research continues to unfold, there is a growing demand for a broader range of medical foods designed to meet the unique nutritional requirements of individuals with various medical conditions, thereby fueling market growth.

Regulatory Support and Standardization

The medical foods industry has also benefited from robust regulatory frameworks that ensure product safety and efficacy. In confluence with this, regulatory agencies have well-defined guidelines for the classification, labeling, and marketing of medical foods. This has instilled confidence among healthcare providers and consumers alike, encouraging the prescription and use of these specialized products. Apart from this, compliance with rigorous standards ensures that medical foods meet specific nutritional needs based on recognized scientific principles. This regulatory support contributes to establishing the medical foods industry as a credible and essential part of healthcare, promoting its growth.

Medical Foods Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the medical foods market report, along with forecasts at the global, regional and country levels for 2023-2028. Our report has categorized the market based on product, route of administration, application, and distribution channel.

Breakup by Product:

Pills

Powder

Others

Powder holds the largest market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes pills, powder, and others. According to the report, powder accounted for the largest market share.

The medical foods industry is witnessing a growing demand for powder-based products, driven by several key factors. One primary driver is the ease of storage and transportation that powdered formulations offer. Unlike liquid or semi-solid medical foods, powders are less susceptible to spoilage and can have a longer shelf life. This makes them particularly advantageous for healthcare settings that require bulk supplies or for areas where distribution logistics may be challenging. Additionally, powdered medical foods offer versatile consumption options; they can be easily mixed with liquids or incorporated into soft foods, thereby increasing compliance among patients who might have difficulty swallowing pills or consuming liquid formulations. Moreover, the preciseness in dosage adjustment is another market driver. Healthcare providers can accurately customize the dose of nutritional elements by measuring the amount of powder, enabling tailored treatment plans for individual patient needs. Technological advancements in microencapsulation and spray drying techniques have also improved the solubility and taste profile of powdered medical foods, making them more palatable for consumers.

Breakup by Route of Administration:

Oral

Enteral

Oral accounts for the majority of the market share

A detailed breakup and analysis of the market based on the route of administration has also been provided in the report. This includes oral and enteral. According to the report, oral accounted for the largest market share.

The oral route of administration is experiencing significant growth in the medical foods industry, underpinned by the ease of consumption and patient compliance. Oral medical foods, often available in the form of capsules, tablets, or liquid suspensions, are generally easier for patients to take as part of their daily routine, compared to other routes, such as intravenous or injectable forms. This simplicity encourages better adherence to treatment plans, thus improving patient outcomes. Additionally, oral administration is usually more cost-effective and less labor-intensive, which is particularly appealing for healthcare systems aiming to optimize resources. There are no costs associated with specialized administration equipment or healthcare personnel required for injections, thereby making it a financially viable option. Along with this, the development and manufacturing processes for oral medical foods often benefit from well-established technologies and quality control measures, resulting in a quicker time-to-market. Moreover, oral medical foods can be easily integrated into personalized medicine regimes, allowing for adjustments in dosage and timing to meet individual needs. This customization enhances the overall efficacy of treatment, further driving the market for the oral route of administration in medical foods.

Breakup by Application:

ADHD

Depression

Diabetes

Cancer

Alzheimer's Disease

Metabolic Disorders

Others

Diabetes holds the largest market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes ADHD, depression, diabetes, cancer, Alzheimer's disease, metabolic disorders, and others. According to the report, diabetes accounted for the largest market share.

The rising incidence of diabetes globally is a compelling market driver for the medical foods industry. Diabetes often requires long-term dietary management alongside pharmaceutical treatment to control blood sugar levels effectively. Medical foods specifically formulated for diabetic patients offer targeted nutritional components that can aid in glycemic control. As healthcare providers and patients alike recognize the importance of dietary strategies in managing diabetes, there is an increased propensity to incorporate medical foods into treatment plans. This growing awareness is supported by clinical studies that validate the efficacy of specific medical foods in improving diabetes-related outcomes. Moreover, the search for alternatives to pharmaceuticals or complementary treatments with fewer side effects is boosting the demand for medical foods. With diabetes being a chronic condition, long-term use of such medical foods is anticipated, thereby providing a stable and expanding market. The rising healthcare expenditure and growing support from regulatory bodies for safer and more effective treatment options also fuel this trend. Overall, the rise in diabetes cases, coupled with the need for comprehensive treatment approaches that include dietary management, propels the market for medical foods in diabetes applications.

Breakup by Distribution Channel:

Supermarkets

Hospital and Retail Pharmacies

Online Pharmacies

Others

Hospital and retail pharmacies account for the majority of the market share

A detailed breakup and analysis of the market based on the distribution channel has also been provided in the report. This includes supermarkets, hospital and retail pharmacies, online pharmacies, and others. According to the report, hospital and retail pharmacies accounted for the largest market share.

Hospital and retail pharmacies serve as a significant distribution channel for medical foods, driven by various market factors. Additionally, the immediate availability of medical foods in hospital settings facilitates quick initiation of nutritional therapy, often critical for patient recovery or disease management. Along with this, the hospital environment allows for integrated care, where healthcare professionals can directly supervise the usage of medical foods, ensuring proper dosage and compliance. This is particularly relevant for conditions that require acute care or for post-operative patients who might need specialized nutritional support. They play a crucial role in the distribution of medical foods. As healthcare systems increasingly focus on outpatient care and home-based management for chronic conditions, retail pharmacies become the go-to source for long-term supplies of medical foods. The convenience of local or online retail pharmacies makes it easier for patients to maintain their treatment plans. In addition, retail pharmacists are becoming more educated about medical foods, allowing them to offer valuable advice to customers and potentially influence purchasing decisions.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest medical foods market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America exhibited the largest segment.

The medical foods industry in North America is experiencing robust growth, driven by the region's advanced healthcare infrastructure, which enables rapid adoption of innovative medical foods. The strong presence of research institutions and leading companies in the sector also contributes to product development and market penetration. Regulatory support from agencies enhances the credibility of medical foods, encouraging healthcare providers to incorporate them into treatment plans. Additionally, the higher healthcare expenditure in North America allows for the integration of specialized products, including medical foods into mainstream medical care. Apart from this, the rise in lifestyle-related chronic diseases such as obesity, diabetes, and cardiovascular conditions further fuels demand, as medical foods offer targeted dietary management for these issues. Moreover, consumer awareness about the benefits of medical foods is relatively high, thanks to extensive educational campaigns and easily accessible information. Moreover, the growing trend of personalized medicine in the region aligns well with the customization possibilities that medical foods offer, adding another layer of market appeal.

Competitive Landscape:

The key players are investing heavily in research to create innovative medical food formulations that are scientifically proven to address various medical conditions. They are working with healthcare professionals and scientists to ensure their products are effective and safe. Along with this, medical food companies continually refine and expand their product lines to cater to a wide range of medical conditions, such as diabetes, metabolic disorders, and gastrointestinal diseases. Thus, they are developing customized nutritional solutions to manage these conditions. In addition, companies adhere to strict quality control measures and compliance with regulatory standards to maintain the integrity of their medical foods. Apart from this, collaboration with healthcare institutions, research organizations, and advocacy groups is positively influencing the market. These partnerships help validate the efficacy of their products and expand their reach. Furthermore, companies are offering resources, such as dietitian support and educational materials, to help individuals make informed choices. Therefore, this is contributing to the market.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Healthcare Private Limited

Alfasigma S.p.A.

Danone S.A.

Fresenius Kabi AG

Mead Johnson & Company LLC (Reckitt Benckiser)

Medtrition Inc.

Meiji Holdings Co. Ltd.

Metagenics Inc. (Alticor)

Nestle S.A.

Primus Pharmaceuticals Inc.

Targeted Medical Pharma Inc.

Victus Inc.

Recent Developments:

In March 2023, Abbott Healthcare Private Limited stated that its FreeStyle Libre 2 and FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system sensors have received approval from the US Food and Drug Administration (FDA) for connection with AID systems. Abbott changed the sensors to allow for connection with AID systems.

In August 2022, Alfasigma S.p.A. signed a contract for acquiring all of the stock in SOFAR S.p.A., an Italian pharmaceutical business with more than 50 years of experience in the development, manufacture, and distribution of pharmaceuticals, medical devices, and dietary supplements.

In March 2022, Ivenix, Inc. stated that it has signed a binding contract to be bought by Fresenius Kabi. Combining the cutting-edge infusion system from Ivenix with the intravenous fluids and infusion treatment options from Fresenius Kabi will provide American hospitals access to a wide range of infusion goods.

Key Questions Answered in This Report

  • 1. What was the size of the global medical foods market in 2022?
  • 2. What is the expected growth rate of the global medical foods market during 2023-2028?
  • 3. What has been the impact of COVID-19 on the global medical foods market?
  • 4. What are the key factors driving the global medical foods market?
  • 5. What is the breakup of the global medical foods market based on the product?
  • 6. What is the breakup of the global medical foods market based on the route of administration?
  • 7. What is the breakup of the global medical foods market based on the application?
  • 8. What is the breakup of the global medical foods market based on the distribution channel?
  • 9. What are the key regions in the global medical foods market?
  • 10. Who are the key players/companies in the global medical foods market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Medical Foods Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Pills
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Powder
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Enteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 ADHD
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Depression
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diabetes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Alzheimer's Disease
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Metabolic Disorders
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Supermarkets
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospital and Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Alfasigma S.p.A.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Danone S.A.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Fresenius Kabi AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Mead Johnson & Company LLC (Reckitt Benckiser)
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Medtrition Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Meiji Holdings Co. Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Metagenics Inc. (Alticor)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 SWOT Analysis
    • 15.3.9 Nestle S.A.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Primus Pharmaceuticals Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Targeted Medical Pharma Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Victus Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio